| abstract |
The present invention relates to compounds of formula (I), R, R- and S, S-enantiomers thereof, and pharmaceutically acceptable acid addition salts thereof. The compounds of formula (I), the R, R- and S, S-enantiomers thereof, include acute forms of neurodegeneration resulting from stroke or brain injury; Chronic forms of neurodegeneration, such as Alzheimer's disease, Parkinson's disease, Huntington's disease or ALS (Atrophic Lateral Sclerosis); Neurodegeneration associated with bacterial or viral infections; And medicaments for treating diseases including diseases such as schizophrenia, anxiety, depression and chronic / acute pain:n n n Formula I |